Adolescent and Adult Subjects With Asthma and Seasonal Allergic Rhinitis Receiving Advair Diskus or Placebo
Status:
Withdrawn
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The four respiratory drugs being researched in this study have been approved by the US Food
and Drug Administration (FDA) and are currently available by prescription at your drug store.
One of the drugs is for the treatment of asthma alone, one is for treatment of SAR alone, and
one is for treatment of both SAR and asthma. In addition, you will also receive one asthma
rescue drug (albuterol) that is to be used for any breakthrough asthma symptoms that you may
experience throughout the study.
The purpose of this study is to see how well your asthma and SAR are controlled when taking
one of the medicine combinations
Phase:
N/A
Details
Lead Sponsor:
Creighton University
Collaborator:
GlaxoSmithKline
Treatments:
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Montelukast